"Tumor aggressiveness" refers to how quickly and destructively a tumor grows and spreads in the body. A more aggressive tumor is faster-growing and more likely to spread to other parts of the body, potentially making it more difficult to treat.
Full definition
GLUD1 and SLC25A13 have pivotal roles in nutritional stress and are associated
with tumor aggressiveness and poorer prognosis of colorectal cancer.
«An index measures similarity between cancer cells and pluripotent stem cells: The new methodology
measures tumor aggressiveness and the risk of relapse, helping doctors plan treatment.»
Adjusted relative risk ratios (RRR) and 95 % confidence intervals for the association between prostate cancer incidence and the scores of adherence to Western, Prudent, and Mediterranean dietary patterns in MCC - Spain study
by tumor aggressiveness and extension.
A form of genetic variation, called differential RNA splicing, may have a role
in tumor aggressiveness and drug resistance in African American men with prostate cancer.
«Genes may
cause tumor aggressiveness, drug resistance in African - American prostate cancer: Research found many targeted therapies for prostate cancer may not be effective against tumors in African - American men.»
This suggests that occasional exposure to hypoxia either induced by treatments or endogenously present, as often observed in ductal carcinoma in situ and in high - grade tumors, could have profound long - term effects on the CSC content and
consequently tumor aggressiveness.
«An index measures similarity between cancer cells and pluripotent stem cells: The new methodology
measures tumor aggressiveness and the risk of relapse, helping doctors plan treatment.»
Costimulatory B7 - H1 in renal cell carcinoma patients: Indicator
of tumor aggressiveness and potential therapeutic target.
Glutamate dehydrogenase 1 (GLUD1) and SLC25A13 have pivotal roles under glucose - deprived conditions and are associated with
tumor aggressiveness and colorectal cancer prognosis.
Lymph node metastases in cancer patients are associated with
tumor aggressiveness, poorer prognoses, and the recommendation for systemic therapy.
As one of the lead scientists, Johan Thevelin of KU Leuven, stated, the research findings are «able to explain the correlation between the strength of the Warburg effect and
tumor aggressiveness.»